CFTR Modulators: From Mechanism to Targeted Therapeutics

Area of Science:

• Biomedical Sciences
• Molecular Biology
• Genetics

Background:

• Cystic Fibrosis (CF) is a multi-organ disorder caused by loss-of-function variants in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
• Significant scientific progress over three decades has led to improved therapies for CF.
• Over 90% of individuals with CF now have access to treatments targeting dysfunctional CFTR.

Purpose of the Study:

• To trace the development of CF therapies from basic research to clinical application.
• To highlight the role of structural and functional studies in advancing CFTR modulator development.
• To emphasize the mechanistic understanding of how CFTR modulators work.

Main Methods:

• Review of structural and functional studies on CFTR.
• Analysis of the development pathway for CFTR modulators.
• Examination of the transition of CF therapies from bench to bedside.

Main Results:

• The identification of the CFTR gene paved the way for therapeutic advancements.
• CFTR modulators directly bind to and correct defects in the CFTR protein.
• These modulators have transformed CF from a life-threatening illness into a treatable disease.

Conclusions:

• CFTR modulators represent a major breakthrough in treating cystic fibrosis.
• Continued research into CFTR structure and function is crucial for further therapeutic development.
• The success of CFTR modulators underscores the importance of basic science in clinical applications.